Terms: = Brain cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Clinical Outcome
3 results:
1. Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse.
Chargari C; Feuvret L; Levy A; Lamproglou I; Assouline A; Hemery C; Ghorbal L; Lopez S; Tep B; G GB; Lang P; Laigle-Donadey F; Cornu P; Mazeron JJ; Simon JM
Br J Neurosurg; 2010 Aug; 24(4):460-7. PubMed ID: 20726753
[TBL] [Abstract] [Full Text] [Related]
2. Nestin, PDGFRbeta, CXCL12 and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information.
Maderna E; Salmaggi A; Calatozzolo C; Limido L; Pollo B
Cancer Biol Ther; 2007 Jul; 6(7):1018-24. PubMed ID: 17611402
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas.
Calatozzolo C; Maderna E; Pollo B; Gelati M; Marras C; Silvani A; Croci D; Boiardi A; Salmaggi A
Cancer Biol Ther; 2006 Jul; 5(7):827-32. PubMed ID: 16760646
[TBL] [Abstract] [Full Text] [Related]
